About Amgen
Industry:
Biotechnology
Founded:
1980
Founders:
George Rathmann
Status:
Public (NASDAQ: AMGN)
Funding & Growth
Total Raised:
N/A
Valuation:
$160B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Biotech pioneer
- • Strong benefits
- • Good work-life balance
- • Multiple therapeutic areas
- • Southern California location
✗ Cons
- • Thousand Oaks location
- • Large company feel
- • Some legacy systems
- • Competitive internally